Quest Diagnostics NYSE DGX
$134.26 -1.16 -0.86%
Today share price
USA
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Показатель: 40 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

15.04B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

19.22B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.04
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

112.00M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-2.63 %
Upcoming events Quest Diagnostics All events
No upcoming events scheduled

Stock chart Quest Diagnostics

Stock analysis Quest Diagnostics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

Mer
17.77 19.94
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

Mer
2.38 2.27
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

Mer
10.87 10.51
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

Mer
2.36 1.97
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

Mer
13.15 12.01

Price change Quest Diagnostics per year

111.81$ 159.87$
Min Max

Summary analysis Quest Diagnostics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Quest Diagnostics

Revenue and net income Quest Diagnostics

All parameters
Stock news Quest Diagnostics All news

Quest Diagnostics Boosts Dividend by 5.6%

Quest Diagnostics Boosts Dividend by 5.6%

Quest Diagnostics profit falls 12%, but beats estimate

Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease

Quest Diagnostics Unveils Consumer-Initiated Alzheimer's Test >DGX

Quest Diagnostics Unveils Consumer-Initiated Alzheimer's Test >DGX

Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease

Quest Diagnostics Cuts Profit Outlook Amid Higher Labor Costs

Quest Diagnostics Cuts Profit Outlook Amid Higher Labor Costs

Quest Diagnostics 2Q Revenue Falls on Lower Productivity Effects

Quest Diagnostics 2Q Revenue Falls on Lower Productivity Effects

Quest Diagnostics to Buy Haystack Oncology for Up to $450 Million >DGX

Quest Diagnostics to Buy Haystack Oncology for Up to $450 Million >DGX

Quest Diagnostics revenue declines amid steep fall in COVID tests

Quest Diagnostics Boosts Quarterly Dividend, Buyback Program >DGX

Quest Diagnostics Boosts Quarterly Dividend, Buyback Program >DGX

Quest Diagnostics raises quarterly dividend by 7.6% to 71 cents a share, boosts share buyback by $1 billion

Quest Diagnostics earnings fall but beat expectations, even as COVID-19 testing revenue drops 55%

Quest Diagnostics profit drops but testing firm raises 2022 view

Quest Diagnostics Begins Testing for Monkeypox

About company Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Address:
500 Plaza Drive, Secaucus, NJ, United States, 07094
Company name: Quest Diagnostics
Issuer ticker: DGX
ISIN: US74834L1008
Country: USA
Exchange: NYSE
Currency: $
IPO date: 1996-12-17
Sector: Healthcare
Industry: Health Care Providers & Services
Site: https://www.questdiagnostics.com

On which stock exchange are Quest Diagnostics (DGX) stocks traded?

Quest Diagnostics (DGX) stocks are traded on NYSE.

What is the ticker of Quest Diagnostics stocks (DGX)?

The stock ticker of Quest Diagnostics’s stocks or in other words, the code is DGX. The stocks are currently listed on the NYSE exchange.

In which sector and industry does Quest Diagnostics (DGX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Quest Diagnostics (DGX) belongs to the «Healthcare» sector and the «Health Care Providers & Services» industry.

In what currency are Quest Diagnostics (DGX) stocks traded?

Quest Diagnostics (DGX) stocks are traded on the NYSE exchange in dollars.

What is the price of Quest Diagnostics (DGX) stocks today?

The current price of Quest Diagnostics stocks on 29.04.2024 is 134.26 dollars. per share.

What is the dynamics of Quest Diagnostics (DGX) stocks from the beginning of the year?

Quest Diagnostics (DGX) quotes have increased by -4.66% from the beginning of the year up to 134.26 dollars. per 1 stocks.

How much did Quest Diagnostics (DGX) stocks increase in апреле 2024?

This month Quest Diagnostics (DGX) quotes have increased by -0.38% to 134.26 dollars. per share.

How much are Quest Diagnostics (DGX) stocks worth?

Today, on October, 29.04.2024 Quest Diagnostics’s (DGX) stocks cost 134.26 dollars..

What is the market capitalization of Quest Diagnostics (DGX)?

Capitalization is the market value of Quest Diagnostics (DGX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Quest Diagnostics (DGX) is estimated at about 15037120000 dollars.